These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36157448)

  • 1. Lipocalin-2 is associated with FGF23 in WNT1 and PLS3 osteoporosis.
    Loid P; Hauta-Alus H; Mäkitie O; Magnusson P; Mäkitie RE
    Front Endocrinol (Lausanne); 2022; 13():954730. PubMed ID: 36157448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers in WNT1 and PLS3 Osteoporosis: Altered Concentrations of DKK1 and FGF23.
    Mäkitie RE; Kämpe A; Costantini A; Alm JJ; Magnusson P; Mäkitie O
    J Bone Miner Res; 2020 May; 35(5):901-912. PubMed ID: 31968132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteocyte Protein Expression Is Altered in Low-Turnover Osteoporosis Caused by Mutations in WNT1 and PLS3.
    Wesseling-Perry K; Mäkitie RE; Välimäki VV; Laine T; Laine CM; Välimäki MJ; Pereira RC; Mäkitie O
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2340-2348. PubMed ID: 28379384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teriparatide Treatment in Patients With WNT1 or PLS3 Mutation-Related Early-Onset Osteoporosis: A Pilot Study.
    Välimäki VV; Mäkitie O; Pereira R; Laine C; Wesseling-Perry K; Määttä J; Kirjavainen M; Viljakainen H; Välimäki MJ
    J Clin Endocrinol Metab; 2017 Feb; 102(2):535-544. PubMed ID: 27732335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone material properties and response to teriparatide in osteoporosis due to WNT1 and PLS3 mutations.
    Fratzl-Zelman N; Wesseling-Perry K; Mäkitie RE; Blouin S; Hartmann MA; Zwerina J; Välimäki VV; Laine CM; Välimäki MJ; Pereira RC; Mäkitie O
    Bone; 2021 May; 146():115900. PubMed ID: 33618074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical Care Use Among Patients with Monogenic Osteoporosis Due to Rare Variants in LRP5, PLS3, or WNT1.
    Verdonk SJE; Storoni S; Zhytnik L; Zhong W; Pals G; van Royen BJ; Elting MW; Maugeri A; Eekhoff EMW; Micha D
    Calcif Tissue Int; 2023 Aug; 113(2):186-194. PubMed ID: 37277619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipocalin 2 serum levels correlate with age and bone turnover biomarkers in healthy subjects but not in postmenopausal osteoporotic women.
    Maurizi A; Ponzetti M; Gautvik KM; Reppe S; Teti A; Rucci N
    Bone Rep; 2021 Jun; 14():101059. PubMed ID: 34026950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel splicing mutation and genotype-phenotype correlations in rare PLS3-related childhood-onset osteoporosis.
    Wu Z; Feng Z; Zhu X; Dai Z; Min K; Qiu Y; Yi L; Xu L; Zhu Z
    Orphanet J Rare Dis; 2022 Jun; 17(1):247. PubMed ID: 35752817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique, Gender-Dependent Serum microRNA Profile in PLS3 Gene-Related Osteoporosis.
    Mäkitie RE; Hackl M; Weigl M; Frischer A; Kämpe A; Costantini A; Grillari J; Mäkitie O
    J Bone Miner Res; 2020 Oct; 35(10):1962-1973. PubMed ID: 32453450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Markers of Bone Fragility in Hemodialysis Patients: A Monocentric Study.
    Slouma M; Aissaoui T; Abbes M; Bahlous A; Laadhar L; Smaoui W; Gharsallah I; Ben Moussa F; Elleuch M; Sahli H; Cheour E
    J Clin Densitom; 2021; 24(1):22-27. PubMed ID: 33288423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
    Bielesz BO; Hecking M; Plischke M; Cejka D; Kieweg H; Haas M; Marculescu R; Hörl WH; Bieglmayer C; Sunder-Plassmann G
    Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates of β-isomerized C-terminal telopeptide of type I collagen (β-CTX), N-terminal propeptide of type I collagen (PINP), osteocalcin, intact fibroblast growth factor 23 and uncarboxylated-unphosphorylated matrix-Gla protein-a cooperation between the EFLM Working Group on Biological Variation and the International Osteoporosis Foundation-International Federation of Clinical Chemistry Committee on Bone Metabolism.
    Cavalier E; Lukas P; Bottani M; Aarsand AK; Ceriotti F; Coşkun A; Díaz-Garzón J; Fernàndez-Calle P; Guerra E; Locatelli M; Sandberg S; Carobene A;
    Osteoporos Int; 2020 Aug; 31(8):1461-1470. PubMed ID: 32270253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel splice mutation in PLS3 causes X-linked early onset low-turnover osteoporosis.
    Laine CM; Wessman M; Toiviainen-Salo S; Kaunisto MA; Mäyränpää MK; Laine T; Pekkinen M; Kröger H; Välimäki VV; Välimäki MJ; Lehesjoki AE; Mäkitie O
    J Bone Miner Res; 2015 Mar; 30(3):510-8. PubMed ID: 25209159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Genetic Forms of Childhood-Onset Primary Osteoporosis.
    Kämpe AJ; Mäkitie RE; Mäkitie O
    Horm Res Paediatr; 2015; 84(6):361-9. PubMed ID: 26517534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mineral bone disorder and osteoporosis in hemodialysis patients.
    Slouma M; Sahli H; Bahlous A; Laadhar L; Smaoui W; Rekik S; Gharsallah I; Sallami M; Moussa FB; Elleuch M; Cheour E
    Adv Rheumatol; 2020 Feb; 60(1):15. PubMed ID: 32102689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans.
    Imel EA; Peacock M; Gray AK; Padgett LR; Hui SL; Econs MJ
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3541-9. PubMed ID: 21880793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of plasma neutrophil gelatinase-associated lipocalin with parameters of CKD-MBD in maintenance hemodialysis patients.
    Jia XY; Wei K; Chen J; Xi LH; Kong XL; Wei Y; Wang L; Wang ZS; Liu YP; Liang LM; Xu DM
    J Bone Miner Metab; 2021 Nov; 39(6):1058-1065. PubMed ID: 34392464
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Mäkitie RE; Niinimäki T; Suo-Palosaari M; Kämpe A; Costantini A; Toiviainen-Salo S; Niinimäki J; Mäkitie O
    Front Endocrinol (Lausanne); 2020; 11():393. PubMed ID: 32655496
    [No Abstract]   [Full Text] [Related]  

  • 19. Reference intervals in Danish children and adolescents for bone turnover markers carboxy-terminal cross-linked telopeptide of type I collagen (β-CTX), pro-collagen type I N-terminal propeptide (PINP), osteocalcin (OC) and bone-specific alkaline phosphatase (bone ALP).
    Diemar SS; Lylloff L; Rønne MS; Møllehave LT; Heidemann M; Thuesen BH; Johannesen J; Schou AJ; Husby S; Wedderkopp N; Mølgaard C; Jørgensen NR
    Bone; 2021 May; 146():115879. PubMed ID: 33561588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study.
    Eisenga MF; De Jong MA; Van der Meer P; Leaf DE; Huls G; Nolte IM; Gaillard CAJM; Bakker SJL; De Borst MH
    PLoS Med; 2019 Jun; 16(6):e1002818. PubMed ID: 31170159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.